Janet Pellegrino
Nurse Practitioner · North Andover, MANPI 1558359737
Payments from drug & device makers
Across 215 payments — averaging $24.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cequr Corporation$926
- Pfizer$449
- Novo Nordisk$404
- Lilly USA, LLC$363
- Xeris Pharmaceuticals, Inc.$323
- Amgen$301
- plus $3K from 29 others
What the payments were for
- Food & beverage$5,357100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cequr Corporation | 4 | $926 |
| Pfizer | 23 | $449 |
| Novo Nordisk | 22 | $404 |
| Lilly USA, LLC | 17 | $363 |
| Xeris Pharmaceuticals, Inc. | 15 | $323 |
| Amgen | 15 | $301 |
| AstraZeneca | 15 | $285 |
| Boehringer Ingelheim | 14 | $277 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $166 |
| AbbVie | 6 | $155 |
| Sanofi-aventis U.S. LLC | 3 | $148 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $145 |
| Exact Sciences | 5 | $122 |
| Bausch Health US, LLC | 5 | $114 |
| Idorsia Pharmaceuticals US Inc | 5 | $113 |
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| GSK | 4 | $93 |
| Ultragenyx Pharmaceutical Inc. | 4 | $88 |
| Novartis | 5 | $78 |
| Mannkind Corporation | 4 | $73 |
| Genentech USA, Inc. | 5 | $70 |
| Corcept Therapeutics | 3 | $66 |
| Teva Pharmaceuticals USA, Inc. | 3 | $66 |
| Ardelyx, Inc. | 3 | $62 |
| Averitas Pharma Inc. | 2 | $57 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $49 |
| Zealand Pharma US, Inc. | 2 | $43 |
| Dexcom, Inc. | 1 | $40 |
| Medtronic | 2 | $37 |
| Bayer | 2 | $34 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| Ascendis Pharma Endocrinology Inc | 1 | $26 |
| Abbott | 1 | $24 |
| Johnson & Johnson | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CeQur Simplicity$926
- TOUJEO$101
How this compares
$5,357 in reported general payments places this provider in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Citalopram HbrCitalopram Hydrobromide | 11 | $134 |
| Levothyroxine Sodium | 11 | $134 |
| Lisinopril | 17 | $76 |
| Omeprazole | 11 | $50 |
| Lorazepam | 16 | $46 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in North Andover
- Alison McManusBoston$346K
- Lauri WelchNorth Chelmsford$110K
- Teresa FogarenBoston$102K
- Carolyn MetivierBoston$93K
- Deborah GearySalem$80K
- Amberly ChaplinWorcester$56K
- Darlene MadoreBrockton$42K
- Nancy SydowN Chelmsford$35K
- Miu Lai NgBoston$33K
- Victoria Garcia AlbeaStoneham$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.